Answers are grounded in this paper and cite their sources.
By the use of pseudo‐high dilution techniques a 40‐membered cyclic arylene sulfone 4, n = 1 was produced in 67% yield by “1 + 1 cyclization” of 4,4′‐dichlorodiphenyl sulfone with 4,4′‐bis(p‐hydroxyphenylisopropylidene phenoxy)diphenyl sulfone, derived in turn from bisphenol‐A and the dihalosulfone. This is a significant improvement over our previously reported yield of 11%. However, the use of cesium carbonate did not result in a yield improvement, i.e., no “cesium effect” was observed. The purity of macrocycle 4, n = 1 was established by high‐performance liquid chromatography (HPLC), NMR spectroscopy and fast atom bombardment mass spectrosccopy (FAB MS). Macrocycle 4, n = 1 has poor solubility due to its crystallinity (Tm = ca. 500°C), but does have high thermal stability (5% weight loss at 507°C in air). HPLC and FAB MS demonstrated that other homologous macrocyclic products resulted from “2 + 2 cyclization” (4, n = 3), “3 + 3 cyclization” (4, n = 5) and backbiting ether exchange reactions (4, n = 2). The high melting point of 4, n = 1 precludes its use as a monomer for melt ring opening polymerization, but this study provides a methodology for the synthesis of other cyclic monomers designed to have lower melting points and be useful in melt ring opening polymerizations.
No takes yet. Share an insight, caveat, or question.
Xie et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: